Avricore Health (AVCRF) Gross Margin (2015 - 2025)
Avricore Health (AVCRF) reported Gross Margin of 139.6% for Q3 2025, down 17598.0% year-over-year from N/an in Q3 2024, and up 16.72% quarter-over-quarter from 167.63% in Q2 2025.
Avricore Health (AVCRF) Gross Margin (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of Gross Margin data on file, last reported at 139.6% in Q3 2025.
- Gross Margin for Q3 2025 came in at 139.6%, down 17598.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 39.71% (up 173.0% YoY), and the FY2025 annual result was 44.63%, up 534.0% from the prior year.
- Gross Margin improved to 139.6% in Q3 2025 per AVCRF's latest filing, from 167.63% in the prior quarter.
- Over five years, Gross Margin peaked at 79.78% in Q1 2025 and troughed at 167.63% in Q2 2025.
- A 5-year average of 10.64% and a median of 29.87% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2025: Gross Margin soared 5249 bps in 2022, then sank 20310 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 26.48% in 2021, then plunged by 35 bps to 17.28% in 2022, then soared by 114 bps to 37.02% in 2023, then slipped by 2 bps to 36.38% in 2024, then tumbled by 484 bps to 139.6% in 2025.
- Business Quant data shows AVCRF's Gross Margin at 139.6% in Q3 2025, 167.63% in Q2 2025, and 79.78% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 87.77% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 70.37% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 60.34% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 63.35% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 53.95% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 99.91% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 32.64% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 66.09% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 58.68% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -139.60% |
| Jun 30, 2025 | -167.63% |
| Mar 31, 2025 | 79.78% |
| Sep 30, 2024 | 36.38% |
| Jun 30, 2024 | 35.47% |
| Mar 31, 2024 | 43.12% |
| Dec 31, 2023 | 37.02% |
| Sep 30, 2023 | 27.46% |
| Jun 30, 2023 | 41.87% |
| Mar 31, 2023 | 33.48% |
| Dec 31, 2022 | 17.28% |
| Sep 30, 2022 | 37.74% |
| Jun 30, 2022 | 32.28% |
| Mar 31, 2022 | 21.38% |
| Dec 31, 2021 | 26.48% |
| Sep 30, 2021 | 27.37% |
| Jun 30, 2021 | -20.21% |
| Mar 31, 2021 | 21.74% |
| Dec 31, 2020 | 27.47% |
| Sep 30, 2020 | 58.86% |